Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Oct 1, 2016

Sanofi and Regeneron Announce Positive Dupixent® (dupilumab) Phase 3 Atopic Dermatitis Data Published in The New England Journal of Medicine

- Data to be presented today during a late breaking abstract session at the 25th Annual European Academy of Dermatology and Venereology (EADV) Congress -
Sep 26, 2016

BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika

Funds will be used for phase II development and manufacturing
Sep 26, 2016

Sanofi and Regeneron Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA
Sep 22, 2016

Annual Sanofi Pasteur and VaxServe Community Fundraiser Breaks $870,000 for Local Families in Need
Sep 12, 2016

Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform

- Joshua Riff, M.D., Named Chief Executive Officer -

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.